ILS and Zinsser Analytic Shareholders Sell to Gardner Denver Medical

Kaye Scholer Frankfurt represented the shareholders of Germany-based ILS Innovative Labor Systeme and Zinsser Analytic (ZA) in the sale of all of their shares in both companies to Gardner Denver Medical, a KKR portfolio company. Starting September 1, 2016, ILS and ZA are part of Gardner Denver Medical Group.

“With Gardner Denver, we have found a new owner who shares our mission and is committed to building on the business we started 46 years ago,” said ILS and ZA owners Werner and Christel Zinsser.

ILS is a leading manufacturer of glass syringes and a global supplier to the world's leading laboratory equipment manufacturers, laboratories and laboratory consumables distributors. ILS is located in Stützerbach, Thuringia, Germany, an area with a long history of glass manufacturing. ZA, headquartered in Frankfurt am Main, Germany, is an established provider of customized laboratory solutions and complementary consumable products. ZA has unique capabilities in developing automated fluid and powder handling systems for the biochemical, pharmaceutical and diagnostic research markets.

Pennsylvania-based Gardner Denver Medical is a leader in flow-control products for medical, life sciences and selected other industries. The ILS and Zinsser acquisitions are expected to further its strategic vision of being a fully integrated, unique single-source provider of technical solutions of high-qualified laboratory automation and appropriate syringe systems.

Frankfurt-based Antitrust partner Dr. Sebastian Jungermann led the Kaye Scholer transaction team, which included partners Dr. Annette Bödeker (Corporate, M&A), Dr. Martin Weger (Tax) and Wolfgang Leip (IP), and associates Pascal Heynen (Corporate, Tax), Dr. Jens Steger (Antitrust), Nina Marcus (Employment & Labor) and Maximilian Reichl (Litigation).